Ligand Pharmaceuticals, Inc. (LGND)
319.55
+7.54
(+2.42%)
USD |
NASDAQ |
Jul 02, 16:00
319.16
-0.39
(-0.12%)
After-Hours: 20:00
Ligand Pharmaceuticals Price : 319.55 for July 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 02, 2026 | 314.81 | 320.00 | 308.76 | 319.55 | 368157.0 |
| Jul 01, 2026 | 315.20 | 318.41 | 305.31 | 312.01 | 521622.0 |
| Jun 30, 2026 | 315.00 | 320.99 | 311.94 | 316.09 | 879069.0 |
| Jun 29, 2026 | 303.67 | 314.80 | 297.41 | 314.04 | 539306.0 |
| Jun 26, 2026 | 294.56 | 305.71 | 286.00 | 303.59 | 1.251M |
| Jun 25, 2026 | 288.34 | 300.12 | 288.34 | 295.92 | 711085.0 |
| Jun 24, 2026 | 283.35 | 288.46 | 278.65 | 284.91 | 548917.0 |
| Jun 23, 2026 | 259.35 | 282.53 | 258.00 | 279.44 | 2.298M |
| Jun 22, 2026 | 267.73 | 272.79 | 245.00 | 262.17 | 819521.0 |
| Jun 18, 2026 | 267.06 | 276.20 | 265.88 | 274.88 | 609561.0 |
| Jun 17, 2026 | 256.95 | 267.27 | 255.00 | 263.14 | 354977.0 |
| Jun 16, 2026 | 255.11 | 258.21 | 250.37 | 255.25 | 220585.0 |
| Jun 15, 2026 | 254.26 | 257.32 | 252.65 | 253.25 | 159043.0 |
| Jun 12, 2026 | 254.99 | 259.03 | 250.49 | 255.54 | 247086.0 |
| Jun 11, 2026 | 251.04 | 258.56 | 247.00 | 254.57 | 274598.0 |
| Jun 10, 2026 | 245.00 | 257.19 | 245.00 | 248.24 | 240272.0 |
| Jun 09, 2026 | 241.98 | 245.00 | 237.00 | 243.28 | 173529.0 |
| Jun 08, 2026 | 239.76 | 240.70 | 236.09 | 237.75 | 219151.0 |
| Jun 05, 2026 | 235.75 | 240.53 | 235.65 | 237.00 | 174946.0 |
| Jun 04, 2026 | 235.12 | 241.10 | 234.42 | 235.91 | 210387.0 |
| Jun 03, 2026 | 232.57 | 234.88 | 231.31 | 234.40 | 157020.0 |
| Jun 02, 2026 | 229.43 | 234.09 | 227.76 | 232.76 | 185122.0 |
| Jun 01, 2026 | 228.68 | 230.73 | 222.76 | 229.78 | 203667.0 |
| May 29, 2026 | 234.79 | 237.14 | 229.98 | 231.96 | 153567.0 |
| May 28, 2026 | 233.66 | 237.84 | 231.66 | 234.66 | 126406.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Organon & Co. | 13.55 |
| Johnson & Johnson | 263.04 |
| Eli Lilly & Co. | 1213.91 |
| Merck & Co., Inc. | 129.56 |
| ANI Pharmaceuticals, Inc. | 86.03 |
Price Related Metrics
| PE Ratio | 43.33 |
| PS Ratio | 23.74 |
| Price to Book Value | 6.418 |
| Price to Free Cash Flow | 57.14 |
| Earnings Yield | 2.31% |
| Market Cap | 6.400B |
| Operating PE Ratio | 64.38 |
| Normalized PE Ratio | 50.77 |